{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T15:26:07Z","timestamp":1740151567049,"version":"3.37.3"},"reference-count":66,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["SPP1230","MO 886\/4-1","Cluster of Excellence REBIRTH (Exc 62\/1)","HBRS; DFG, GSC 108"],"award-info":[{"award-number":["SPP1230","MO 886\/4-1","Cluster of Excellence REBIRTH (Exc 62\/1)","HBRS; DFG, GSC 108"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Exp Clin Cancer Res"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s13046-015-0260-4","type":"journal-article","created":{"date-parts":[[2015,12,12]],"date-time":"2015-12-12T03:26:31Z","timestamp":1449890791000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Chemoprotection of murine hematopoietic cells by combined gene transfer of cytidine deaminase (CDD) and multidrug resistance 1 gene (MDR1)"],"prefix":"10.1186","volume":"34","author":[{"given":"Sebastian","family":"Brennig","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nico","family":"Lachmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Theresa","family":"Buchegger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miriam","family":"Hetzel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Axel","family":"Schambach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Moritz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,12,12]]},"reference":[{"issue":"2","key":"260_CR1","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1080\/14653240152584640","volume":"3","author":"T Moritz","year":"2001","unstructured":"Moritz T, Williams DA. Marrow protection - transduction of hematopoietic cells with drug resistance genes. Cytotherapy. 2001;3(2):67\u201384.","journal-title":"Cytotherapy"},{"issue":"6","key":"260_CR2","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/nrc823","volume":"2","author":"BP Sorrentino","year":"2002","unstructured":"Sorrentino BP. Gene therapy to protect haematopoietic cells from cytotoxic cancer drugs. Nat Rev Cancer. 2002;2(6):431\u201341.","journal-title":"Nat Rev Cancer"},{"issue":"133","key":"260_CR3","doi-asserted-by":"crossref","first-page":"133ra157","DOI":"10.1126\/scitranslmed.3003425","volume":"4","author":"JE Adair","year":"2012","unstructured":"Adair JE, Beard BC, Trobridge GD, Neff T, Rockhill JK, Silbergeld DL, et al. Extended survival of glioblastoma patients after chemoprotective HSC gene therapy. Sci Transl Med. 2012;4(133):133ra157.","journal-title":"Sci Transl Med"},{"issue":"9","key":"260_CR4","doi-asserted-by":"crossref","first-page":"4082","DOI":"10.1172\/JCI76739","volume":"124","author":"JE Adair","year":"2014","unstructured":"Adair JE, Johnston SK, Mrugala MM, Beard BC, Guyman LA, Baldock AL, et al. Gene therapy enhances chemotherapy tolerance and efficacy in glioblastoma patients. J Clin Invest. 2014;124(9):4082\u201392.","journal-title":"J Clin Invest"},{"issue":"3","key":"260_CR5","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1124\/jpet.107.123414","volume":"322","author":"JL Gori","year":"2007","unstructured":"Gori JL, Podetz-Pedersen K, Swanson D, Karlen AD, Gunther R, Somia NV, et al. Protection of mice from methotrexate toxicity by ex vivo transduction using lentivirus vectors expressing drug-resistant dihydrofolate reductase. J Pharmacol Exp Ther. 2007;322(3):989\u201397.","journal-title":"J Pharmacol Exp Ther"},{"issue":"6","key":"260_CR6","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1182\/blood.V87.6.2579.bloodjournal8762579","volume":"87","author":"HT Spencer","year":"1996","unstructured":"Spencer HT, Sleep SE, Rehg JE, Blakley RL, Sorrentino BP. A gene transfer strategy for making bone marrow cells resistant to trimetrexate. Blood. 1996;87(6):2579\u201387.","journal-title":"Blood"},{"issue":"1","key":"260_CR7","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1084\/jem.166.1.210","volume":"166","author":"DA Williams","year":"1987","unstructured":"Williams DA, Hsieh K, DeSilva A, Mulligan RC. Protection of bone marrow transplant recipients from lethal doses of methotrexate by the generation of methotrexate-resistant bone marrow. J Exp Med. 1987;166(1):210\u20138.","journal-title":"J Exp Med"},{"issue":"3","key":"260_CR8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0059594","volume":"8","author":"R Choudhary","year":"2013","unstructured":"Choudhary R, Baturin D, Fosmire S, Freed B, Porter CC. Knockdown of HPRT for selection of genetically modified human hematopoietic progenitor cells. PLoS One. 2013;8(3):e59594.","journal-title":"PLoS One"},{"key":"260_CR9","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1146\/annurev.bi.62.070193.002125","volume":"62","author":"MM Gottesman","year":"1993","unstructured":"Gottesman MM, Pastan I. Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu Rev Biochem. 1993;62:385\u2013427.","journal-title":"Annu Rev Biochem"},{"issue":"5","key":"260_CR10","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1002\/ijc.10206","volume":"98","author":"A Carpinteiro","year":"2002","unstructured":"Carpinteiro A, Peinert S, Ostertag W, Zander AR, Hossfeld DK, Kuhlcke K, et al. Genetic protection of repopulating hematopoietic cells with an improved MDR1-retrovirus allows administration of intensified chemotherapy following stem cell transplantation in mice. Int J Cancer. 2002;98(5):785\u201392.","journal-title":"Int J Cancer"},{"issue":"9","key":"260_CR11","doi-asserted-by":"crossref","first-page":"3407","DOI":"10.1182\/blood.V88.9.3407.bloodjournal8893407","volume":"88","author":"HG Eckert","year":"1996","unstructured":"Eckert HG, Stockschlader M, Just U, Hegewisch-Becker S, Grez M, Uhde A, et al. High-dose multidrug resistance in primary human hematopoietic progenitor cells transduced with optimized retroviral vectors. Blood. 1996;88(9):3407\u201315.","journal-title":"Blood"},{"issue":"4","key":"260_CR12","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1089\/10430340050015743","volume":"11","author":"P Hafkemeyer","year":"2000","unstructured":"Hafkemeyer P, Licht T, Pastan I, Gottesman MM. Chemoprotection of hematopoietic cells by a mutant P-glycoprotein resistant to a potent chemosensitizer of multidrug-resistant cancers. Hum Gene Ther. 2000;11(4):555\u201365.","journal-title":"Hum Gene Ther"},{"issue":"8","key":"260_CR13","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1038\/sj.gt.3300962","volume":"6","author":"J Jelinek","year":"1999","unstructured":"Jelinek J, Rafferty JA, Cmejla R, Hildinger M, Chinnasamy D, Lashford LS, et al. A novel dual function retrovirus expressing multidrug resistance 1 and O6-alkylguanine-DNA-alkyltransferase for engineering resistance of haemopoietic progenitor cells to multiple chemotherapeutic agents. Gene Ther. 1999;6(8):1489\u201393.","journal-title":"Gene Ther"},{"issue":"8","key":"260_CR14","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1002\/jgm.914","volume":"8","author":"TD Southgate","year":"2006","unstructured":"Southgate TD, Garside E, Margison GP, Fairbairn LJ. Dual agent chemoprotection by retroviral co-expression of either MDR1 or MRP1 with the P140K mutant of O6-methylguanine-DNA-methyl transferase. J Gene Med. 2006;8(8):972\u20139.","journal-title":"J Gene Med"},{"issue":"6","key":"260_CR15","first-page":"947","volume":"3","author":"M Suzuki","year":"1997","unstructured":"Suzuki M, Sugimoto Y, Tsukahara S, Okochi E, Gottesman MM, Tsuruo T. Retroviral coexpression of two different types of drug resistance genes to protect normal cells from combination chemotherapy. Clin Cancer Res. 1997;3(6):947\u201354.","journal-title":"Clin Cancer Res"},{"issue":"6","key":"260_CR16","first-page":"973","volume":"2","author":"I Aksentijevich","year":"1996","unstructured":"Aksentijevich I, Cardarelli CO, Pastan I, Gottesman MM. Retroviral transfer of the human MDR1 gene confers resistance to bisantrene-specific hematotoxicity. Clin Cancer Res. 1996;2(6):973\u201380.","journal-title":"Clin Cancer Res"},{"issue":"4","key":"260_CR17","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1182\/blood.V79.4.1087.bloodjournal7941087","volume":"79","author":"GH Mickisch","year":"1992","unstructured":"Mickisch GH, Aksentijevich I, Schoenlein PV, Goldstein LJ, Galski H, Stahle C, et al. Transplantation of bone marrow cells from transgenic mice expressing the human MDR1 gene results in long-term protection against the myelosuppressive effect of chemotherapy in mice. Blood. 1992;79(4):1087\u201393.","journal-title":"Blood"},{"issue":"5066","key":"260_CR18","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1126\/science.1352414","volume":"257","author":"BP Sorrentino","year":"1992","unstructured":"Sorrentino BP, Brandt SJ, Bodine D, Gottesman M, Pastan I, Cline A, et al. Selection of drug-resistant bone marrow cells in vivo after retroviral transfer of human MDR1. Science. 1992;257(5066):99\u2013103.","journal-title":"Science"},{"issue":"2","key":"260_CR19","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1089\/10430340252769761","volume":"13","author":"B Schiedlmeier","year":"2002","unstructured":"Schiedlmeier B, Schilz AJ, Kuhlcke K, Laufs S, Baum C, Zeller WJ, et al. Multidrug resistance 1 gene transfer can confer chemoprotection to human peripheral blood progenitor cells engrafted in immunodeficient mice. Hum Gene Ther. 2002;13(2):233\u201342.","journal-title":"Hum Gene Ther"},{"issue":"11","key":"260_CR20","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1038\/cgt.2012.67","volume":"19","author":"P Maier","year":"2012","unstructured":"Maier P, Heckmann D, Spier I, Laufs S, Zucknick M, Allgayer H, et al. F2A sequence linking MGMT(P140K) and MDR1 in a bicistronic lentiviral vector enables efficient chemoprotection of haematopoietic stem cells. Cancer Gene Ther. 2012;19(11):802\u201310.","journal-title":"Cancer Gene Ther"},{"issue":"3","key":"260_CR21","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1038\/gt.2009.133","volume":"17","author":"P Maier","year":"2010","unstructured":"Maier P, Spier I, Laufs S, Veldwijk MR, Fruehauf S, Wenz F, et al. Chemoprotection of human hematopoietic stem cells by simultaneous lentiviral overexpression of multidrug resistance 1 and O(6)-methylguanine-DNA methyltransferase(P140K). Gene Ther. 2010;17(3):389\u201399.","journal-title":"Gene Ther"},{"issue":"5","key":"260_CR22","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1002\/jgm.362","volume":"5","author":"Y Sugimoto","year":"2003","unstructured":"Sugimoto Y, Tsukahara S, Sato S, Suzuki M, Nunoi H, Malech HL, et al. Drug-selected co-expression of P-glycoprotein and gp91 in vivo from an MDR1-bicistronic retrovirus vector Ha-MDR-IRES-gp91. J Gene Med. 2003;5(5):366\u201376.","journal-title":"J Gene Med"},{"issue":"7","key":"260_CR23","first-page":"1619","volume":"5","author":"KH Cowan","year":"1999","unstructured":"Cowan KH, Moscow JA, Huang H, Zujewski JA, O'Shaughnessy J, Sorrentino B, et al. Paclitaxel chemotherapy after autologous stem-cell transplantation and engraftment of hematopoietic cells transduced with a retrovirus containing the multidrug resistance complementary DNA (MDR1) in metastatic breast cancer patients. Clin Cancer Res. 1999;5(7):1619\u201328.","journal-title":"Clin Cancer Res"},{"issue":"26","key":"260_CR24","doi-asserted-by":"crossref","first-page":"15346","DOI":"10.1073\/pnas.93.26.15346","volume":"93","author":"EG Hanania","year":"1996","unstructured":"Hanania EG, Giles RE, Kavanagh J, Fu SQ, Ellerson D, Zu Z, et al. Results of MDR-1 vector modification trial indicate that granulocyte\/macrophage colony-forming unit cells do not contribute to posttransplant hematopoietic recovery following intensive systemic therapy. Proc Natl Acad Sci U S A. 1996;93(26):15346\u201351.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"260_CR25","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1200\/JCO.1998.16.1.165","volume":"16","author":"C Hesdorffer","year":"1998","unstructured":"Hesdorffer C, Ayello J, Ward M, Kaubisch A, Vahdat L, Balmaceda C, et al. Phase I trial of retroviral-mediated transfer of the human MDR1 gene as marrow chemoprotection in patients undergoing high-dose chemotherapy and autologous stem-cell transplantation. J Clin Oncol. 1998;16(1):165\u201372.","journal-title":"J Clin Oncol"},{"issue":"7","key":"260_CR26","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1002\/jgm.1474","volume":"12","author":"J Mitsuhashi","year":"2010","unstructured":"Mitsuhashi J, Hosoyama H, Tsukahara S, Katayama K, Noguchi K, Ito Y, et al. In vivo expansion of MDR1-transduced cells accompanied by a post-transplantation chemotherapy regimen with mitomycin C and methotrexate. J Gene Med. 2010;12(7):596\u2013603.","journal-title":"J Gene Med"},{"issue":"10","key":"260_CR27","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1111\/j.1349-7006.2007.00571.x","volume":"98","author":"S Takahashi","year":"2007","unstructured":"Takahashi S, Aiba K, Ito Y, Hatake K, Nakane M, Kobayashi T, et al. Pilot study of MDR1 gene transfer into hematopoietic stem cells and chemoprotection in metastatic breast cancer patients. Cancer Sci. 2007;98(10):1609\u201316.","journal-title":"Cancer Sci"},{"issue":"6","key":"260_CR28","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1038\/76225","volume":"6","author":"R Abonour","year":"2000","unstructured":"Abonour R, Williams DA, Einhorn L, Hall KM, Chen J, Coffman J, et al. Efficient retrovirus-mediated transfer of the multidrug resistance 1 gene into autologous human long-term repopulating hematopoietic stem cells. Nat Med. 2000;6(6):652\u20138.","journal-title":"Nat Med"},{"issue":"3","key":"260_CR29","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1593\/neo.121954","volume":"15","author":"N Lachmann","year":"2013","unstructured":"Lachmann N, Brennig S, Phaltane R, Flasshove M, Dilloo D, Moritz T. Myeloprotection by cytidine deaminase gene transfer in antileukemic therapy. Neoplasia. 2013;15(3):239\u201348.","journal-title":"Neoplasia"},{"issue":"11","key":"260_CR30","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/S0145-2126(99)00128-9","volume":"23","author":"M Flasshove","year":"1999","unstructured":"Flasshove M, Frings W, Schroder JK, Moritz T, Schutte J, Seeber S. Transfer of the cytidine deaminase cDNA into hematopoietic cells. Leuk Res. 1999;23(11):1047\u201353.","journal-title":"Leuk Res"},{"issue":"11","key":"260_CR31","first-page":"1340","volume":"24","author":"T Neff","year":"1996","unstructured":"Neff T, Blau CA. Forced expression of cytidine deaminase confers resistance to cytosine arabinoside and gemcitabine. Exp Hematol. 1996;24(11):1340\u20136.","journal-title":"Exp Hematol"},{"issue":"12","key":"260_CR32","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1038\/sj.leu.2403977","volume":"19","author":"W Bardenheuer","year":"2005","unstructured":"Bardenheuer W, Lehmberg K, Rattmann I, Brueckner A, Schneider A, Sorg UR, et al. Resistance to cytarabine and gemcitabine and in vitro selection of transduced cells after retroviral expression of cytidine deaminase in human hematopoietic progenitor cells. Leukemia. 2005;19(12):2281\u20138.","journal-title":"Leukemia"},{"issue":"4","key":"260_CR33","doi-asserted-by":"crossref","first-page":"451","DOI":"10.3109\/14653249.2011.646043","volume":"14","author":"S Brennig","year":"2012","unstructured":"Brennig S, Rattmann I, Lachmann N, Schambach A, Williams DA, Moritz T. In vivo enrichment of cytidine deaminase gene-modified hematopoietic cells by prolonged cytosine-arabinoside application. Cytotherapy. 2012;14(4):451\u201360.","journal-title":"Cytotherapy"},{"issue":"9","key":"260_CR34","doi-asserted-by":"crossref","first-page":"2965","DOI":"10.1182\/blood-2006-03-011734","volume":"108","author":"I Rattmann","year":"2006","unstructured":"Rattmann I, Kleff V, Sorg UR, Bardenheuer W, Brueckner A, Hilger RA, et al. Gene transfer of cytidine deaminase protects myelopoiesis from cytidine analogs in an in vivo murine transplant model. Blood. 2006;108(9):2965\u201371.","journal-title":"Blood"},{"issue":"3","key":"260_CR35","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/gt.2012.40","volume":"20","author":"N Lachmann","year":"2013","unstructured":"Lachmann N, Brennig S, Pfaff N, Schermeier H, Dahlmann J, Phaltane R, et al. Efficient in vivo regulation of cytidine deaminase expression in the haematopoietic system using a doxycycline-inducible lentiviral vector system. Gene Ther. 2013;20(3):298\u2013307.","journal-title":"Gene Ther"},{"issue":"6","key":"260_CR36","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1097\/CCO.0b013e328358f62d","volume":"24","author":"GJ Roboz","year":"2012","unstructured":"Roboz GJ. Current treatment of acute myeloid leukemia. Curr Opin Oncol. 2012;24(6):711\u20139.","journal-title":"Curr Opin Oncol"},{"issue":"11","key":"260_CR37","doi-asserted-by":"crossref","first-page":"8463","DOI":"10.1128\/JVI.72.11.8463-8471.1998","volume":"72","author":"T Dull","year":"1998","unstructured":"Dull T, Zufferey R, Kelly M, Mandel RJ, Nguyen M, Trono D, et al. A third-generation lentivirus vector with a conditional packaging system. J Virol. 1998;72(11):8463\u201371.","journal-title":"J Virol"},{"issue":"7","key":"260_CR38","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/sj.gt.3302698","volume":"13","author":"A Schambach","year":"2006","unstructured":"Schambach A, Bohne J, Baum C, Hermann FG, Egerer L, von Laer D, et al. Woodchuck hepatitis virus post-transcriptional regulatory element deleted from X protein and promoter sequences enhances retroviral vector titer and expression. Gene Ther. 2006;13(7):641\u20135.","journal-title":"Gene Ther"},{"issue":"9","key":"260_CR39","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1038\/gt.2011.148","volume":"19","author":"N Lachmann","year":"2012","unstructured":"Lachmann N, Jagielska J, Heckl D, Brennig S, Pfaff N, Maetzig T, et al. MicroRNA-150-regulated vectors allow lymphocyte-sparing transgene expression in hematopoietic gene therapy. Gene Ther. 2012;19(9):915\u201324.","journal-title":"Gene Ther"},{"key":"260_CR40","doi-asserted-by":"crossref","unstructured":"Lachmann N, Brennig S, Hillje R, Schermeier H, Phaltane R, Dahlmann J, et al. Tightly regulated 'all-in-one' lentiviral vectors for protection of human hematopoietic cells from anticancer chemotherapy. Gene Ther. 2015.","DOI":"10.1038\/gt.2015.61"},{"issue":"11","key":"260_CR41","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1038\/sj.gt.3300767","volume":"5","author":"N Eliopoulos","year":"1998","unstructured":"Eliopoulos N, Bovenzi V, Le NL, Momparler LF, Greenbaum M, Letourneau S, et al. Retroviral transfer and long-term expression of human cytidine deaminase cDNA in hematopoietic cells following transplantation in mice. Gene Ther. 1998;5(11):1545\u201351.","journal-title":"Gene Ther"},{"issue":"18","key":"260_CR42","first-page":"4073","volume":"55","author":"JH Doroshow","year":"1995","unstructured":"Doroshow JH, Metz MZ, Matsumoto L, Winters KA, Sakai M, Muramatsu M, et al. Transduction of NIH 3\u00a0T3 cells with a retrovirus carrying both human MDR1 and glutathione S-transferase pi produces broad-range multidrug resistance. Cancer Res. 1995;55(18):4073\u20138.","journal-title":"Cancer Res"},{"issue":"15","key":"260_CR43","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1089\/hum.1997.8.15-1773","volume":"8","author":"J Galipeau","year":"1997","unstructured":"Galipeau J, Benaim E, Spencer HT, Blakley RL, Sorrentino BP. A bicistronic retroviral vector for protecting hematopoietic cells against antifolates and P-glycoprotein effluxed drugs. Hum Gene Ther. 1997;8(15):1773\u201383.","journal-title":"Hum Gene Ther"},{"issue":"5","key":"260_CR44","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1038\/sj.cgt.7700169","volume":"7","author":"S Letourneau","year":"2000","unstructured":"Letourneau S, Palerme JS, Delisle JS, Beausejour CM, Momparler RL, Cournoyer D. Coexpression of rat glutathione S-transferase A3 and human cytidine deaminase by a bicistronic retroviral vector confers in vitro resistance to nitrogen mustards and cytosine arabinoside in murine fibroblasts. Cancer Gene Ther. 2000;7(5):757\u201365.","journal-title":"Cancer Gene Ther"},{"issue":"17","key":"260_CR45","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1089\/hum.1998.9.17-2537","volume":"9","author":"CM Beausejour","year":"1998","unstructured":"Beausejour CM, Le NL, Letourneau S, Cournoyer D, Momparler RL. Coexpression of cytidine deaminase and mutant dihydrofolate reductase by a bicistronic retroviral vector confers resistance to cytosine arabinoside and methotrexate. Hum Gene Ther. 1998;9(17):2537\u201344.","journal-title":"Hum Gene Ther"},{"issue":"3","key":"260_CR46","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.ymthe.2004.06.115","volume":"10","author":"T Budak-Alpdogan","year":"2004","unstructured":"Budak-Alpdogan T, Alpdogan O, Banerjee D, Wang E, Moore MA, Bertino JR. Methotrexate and cytarabine inhibit progression of human lymphoma in NOD\/SCID mice carrying a mutant dihydrofolate reductase and cytidine deaminase fusion gene. Mol Ther. 2004;10(3):574\u201384.","journal-title":"Mol Ther"},{"issue":"15","key":"260_CR47","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1089\/10430349950016834","volume":"10","author":"A Sauerbrey","year":"1999","unstructured":"Sauerbrey A, McPherson JP, Zhao SC, Banerjee D, Bertino JR. Expression of a novel double-mutant dihydrofolate reductase-cytidine deaminase fusion gene confers resistance to both methotrexate and cytosine arabinoside. Hum Gene Ther. 1999;10(15):2495\u2013504.","journal-title":"Hum Gene Ther"},{"issue":"4","key":"260_CR48","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1038\/sj.gt.3301087","volume":"7","author":"T Licht","year":"2000","unstructured":"Licht T, Goldenberg SK, Vieira WD, Gottesman MM, Pastan I. Drug selection of MDR1-transduced hematopoietic cells ex vivo increases transgene expression and chemoresistance in reconstituted bone marrow in mice. Gene Ther. 2000;7(4):348\u201358.","journal-title":"Gene Ther"},{"issue":"6","key":"260_CR49","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1182\/blood-2013-12-546218","volume":"124","author":"CX Wang","year":"2014","unstructured":"Wang CX, Sather BD, Wang X, Adair J, Khan I, Singh S, et al. Rapamycin relieves lentiviral vector transduction resistance in human and mouse hematopoietic stem cells. Blood. 2014;124(6):913\u201323.","journal-title":"Blood"},{"issue":"1","key":"260_CR50","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/mt.2014.173","volume":"23","author":"C Brendel","year":"2015","unstructured":"Brendel C, Goebel B, Daniela A, Brugman M, Kneissl S, Schwable J, et al. CD133-targeted gene transfer into long-term repopulating hematopoietic stem cells. Mol Ther. 2015;23(1):63\u201370.","journal-title":"Mol Ther"},{"issue":"8","key":"260_CR51","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1182\/blood-2014-02-558163","volume":"124","author":"A Girard-Gagnepain","year":"2014","unstructured":"Girard-Gagnepain A, Amirache F, Costa C, Levy C, Frecha C, Fusil F, et al. Baboon envelope pseudotyped LVs outperform VSV-G-LVs for gene transfer into early-cytokine-stimulated and resting HSCs. Blood. 2014;124(8):1221\u201331.","journal-title":"Blood"},{"issue":"4","key":"260_CR52","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1006\/mthe.2000.0050","volume":"1","author":"H Mizuguchi","year":"2000","unstructured":"Mizuguchi H, Xu Z, Ishii-Watabe A, Uchida E, Hayakawa T. IRES-dependent second gene expression is significantly lower than cap-dependent first gene expression in a bicistronic vector. Mol Ther. 2000;1(4):376\u201382.","journal-title":"Mol Ther"},{"issue":"5","key":"260_CR53","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1517\/14712598.5.5.627","volume":"5","author":"AL Szymczak","year":"2005","unstructured":"Szymczak AL, Vignali DA. Development of 2A peptide-based strategies in the design of multicistronic vectors. Expert Opin Biol Ther. 2005;5(5):627\u201338.","journal-title":"Expert Opin Biol Ther"},{"issue":"7","key":"260_CR54","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1182\/blood.V92.7.2269","volume":"92","author":"KD Bunting","year":"1998","unstructured":"Bunting KD, Galipeau J, Topham D, Benaim E, Sorrentino BP. Transduction of murine bone marrow cells with an MDR1 vector enables ex vivo stem cell expansion, but these expanded grafts cause a myeloproliferative syndrome in transplanted mice. Blood. 1998;92(7):2269\u201379.","journal-title":"Blood"},{"issue":"1","key":"260_CR55","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1089\/hum.1998.9.1-33","volume":"9","author":"M Hildinger","year":"1998","unstructured":"Hildinger M, Fehse B, Hegewisch-Becker S, John J, Rafferty JR, Ostertag W, et al. Dominant selection of hematopoietic progenitor cells with retroviral MDR1 co-expression vectors. Hum Gene Ther. 1998;9(1):33\u201342.","journal-title":"Hum Gene Ther"},{"issue":"7","key":"260_CR56","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1038\/sj.gt.3301675","volume":"9","author":"N Eliopoulos","year":"2002","unstructured":"Eliopoulos N, Al-Khaldi A, Beausejour CM, Momparler RL, Momparler LF, Galipeau J. Human cytidine deaminase as an ex vivo drug selectable marker in gene-modified primary bone marrow stromal cells. Gene Ther. 2002;9(7):452\u201362.","journal-title":"Gene Ther"},{"issue":"10","key":"260_CR57","volume":"9","author":"W Li","year":"2014","unstructured":"Li W, Gong X, Sun M, Zhao X, Gong B, Wei H, et al. High-dose cytarabine in acute myeloid leukemia treatment: a systematic review and meta-analysis. PLoS One. 2014;9(10):e110153.","journal-title":"PLoS One"},{"issue":"1","key":"260_CR58","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1182\/blood-2012-07-444851","volume":"121","author":"B Lowenberg","year":"2013","unstructured":"Lowenberg B. Sense and nonsense of high-dose cytarabine for acute myeloid leukemia. Blood. 2013;121(1):26\u20138.","journal-title":"Blood"},{"issue":"4","key":"260_CR59","doi-asserted-by":"crossref","first-page":"214","DOI":"10.2174\/157340311799960645","volume":"7","author":"M Volkova","year":"2011","unstructured":"Volkova M, Russell 3rd R. Anthracycline cardiotoxicity: prevalence, pathogenesis and treatment. Curr Cardiol Rev. 2011;7(4):214\u201320.","journal-title":"Curr Cardiol Rev"},{"issue":"7","key":"260_CR60","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1089\/10430340252898984","volume":"13","author":"C Demaison","year":"2002","unstructured":"Demaison C, Parsley K, Brouns G, Scherr M, Battmer K, Kinnon C, et al. High-level transduction and gene expression in hematopoietic repopulating cells using a human immunodeficiency [correction of imunodeficiency] virus type 1-based lentiviral vector containing an internal spleen focus forming virus promoter. Hum Gene Ther. 2002;13(7):803\u201313.","journal-title":"Hum Gene Ther"},{"issue":"4","key":"260_CR61","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1038\/mt.2008.5","volume":"16","author":"D Zychlinski","year":"2008","unstructured":"Zychlinski D, Schambach A, Modlich U, Maetzig T, Meyer J, Grassman E, et al. Physiological promoters reduce the genotoxic risk of integrating gene vectors. Mol Ther. 2008;16(4):718\u201325.","journal-title":"Mol Ther"},{"issue":"11","key":"260_CR62","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1038\/mt.2009.179","volume":"17","author":"U Modlich","year":"2009","unstructured":"Modlich U, Navarro S, Zychlinski D, Maetzig T, Knoess S, Brugman MH, et al. Insertional transformation of hematopoietic cells by self-inactivating lentiviral and gammaretroviral vectors. Mol Ther. 2009;17(11):1919\u201328.","journal-title":"Mol Ther"},{"issue":"5954","key":"260_CR63","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1126\/science.1171242","volume":"326","author":"N Cartier","year":"2009","unstructured":"Cartier N, Hacein-Bey-Abina S, Bartholomae CC, Veres G, Schmidt M, Kutschera I, et al. Hematopoietic stem cell gene therapy with a lentiviral vector in X-linked adrenoleukodystrophy. Science. 2009;326(5954):818\u201323.","journal-title":"Science"},{"issue":"15","key":"260_CR64","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1056\/NEJMoa1404588","volume":"371","author":"S Hacein-Bey-Abina","year":"2014","unstructured":"Hacein-Bey-Abina S, Pai SY, Gaspar HB, Armant M, Berry CC, Blanche S, et al. A modified gamma-retrovirus vector for X-linked severe combined immunodeficiency. N Engl J Med. 2014;371(15):1407\u201317.","journal-title":"N Engl J Med"},{"issue":"18","key":"260_CR65","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1056\/NEJMoa1106152","volume":"365","author":"A Stasi Di","year":"2011","unstructured":"Di Stasi A, Tey SK, Dotti G, Fujita Y, Kennedy-Nasser A, Martinez C, et al. Inducible apoptosis as a safety switch for adoptive cell therapy. N Engl J Med. 2011;365(18):1673\u201383.","journal-title":"N Engl J Med"},{"issue":"8","key":"260_CR66","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1089\/hum.2009.042","volume":"21","author":"E Preuss","year":"2010","unstructured":"Preuss E, Treschow A, Newrzela S, Brucher D, Weber K, Felldin U, et al. TK.007: A novel, codon-optimized HSVtk(A168H) mutant for suicide gene therapy. Hum Gene Ther. 2010;21(8):929\u201341.","journal-title":"Hum Gene Ther"}],"container-title":["Journal of Experimental &amp; Clinical Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-015-0260-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,12]],"date-time":"2020-09-12T14:47:47Z","timestamp":1599922067000},"score":1,"resource":{"primary":{"URL":"http:\/\/jeccr.biomedcentral.com\/articles\/10.1186\/s13046-015-0260-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,12]]},"references-count":66,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["260"],"URL":"https:\/\/doi.org\/10.1186\/s13046-015-0260-4","relation":{},"ISSN":["1756-9966"],"issn-type":[{"type":"electronic","value":"1756-9966"}],"subject":[],"published":{"date-parts":[[2015,12]]},"article-number":"148"}}